Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Guangdong Jiaying Pharmaceutical Co., Ltd
  6. News
  7. Summary
    002198   CNE1000008P1

GUANGDONG JIAYING PHARMACEUTICAL CO., LTD

(002198)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2023-01-29
7.030 CNY   -0.99%
01/18Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
MT
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lin Shaobin signed cancelled the acquisition of 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong, Huang Zhiyong and Huang Libing

11/01/2021 EST

Lin Shaobin signed Share Transfer Agreement to acquire a 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Chen Yonghong, Huang Zhiyong and Huang Libing for approximately CNY 410 million on June 9, 2021. Under the transaction, Chen Yonghong will transfer 36,280,599 shares representing 7.15% stake, Huang Zhiyong will transfer 3,612,940 shares representing 0.71% stake, and Huang Libing will transfer 707,248 shares representing 0.14% stake at a price of CNY 10 per share. Post transaction, Chen Yonghong will have 192.60401 million shares representing 3.8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd. Lin Shaobin signed cancelled the acquisition of 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Chen Yonghong, Huang Zhiyong and Huang Libing on November 1, 2021. The shareholders and Lin Shaobin have negotiated and reached an agreement on the termination of the agreement to transfer the company?s shares. The main content of the agreement is as follows: The two parties fully negotiated and agreed to cancel the signed "Chen Yonghong, Huang ZhiYong, Huang Libing and Lin Shaobin on the Share Transfer Agreement of Guangdong Jiaying Pharmaceutical Co., the two parties shall not be liable for each other?s breach of contract, nor shall the parties have any outstanding rights and obligations to each other. This cancellation agreement will become effective as soon as it is signed by both parties. After the termination of the agreement transfer, as of the disclosure date of this announcement, Chen Yonghong holds 50,778,500 shares of the company, accounting for 10.01% of the company?s total share capital; Zhiyong holds 24,997,848 shares of the company, accounting for the total share capital of the company 4.93%; Huang Libing holds 707248 shares of the company, accounting for 0.14% of the company's total share capital.


ę S&P Capital IQ 2021
All news about GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
01/18Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
MT
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months ..
CI
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year En..
CI
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarte..
CI
2022Jiaying Pharmaceutical's Profit Crashes 93% in 2021 Despite Revenue Growth
MT
2022Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year En..
CI
2021Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical..
CI
2021Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical..
CI
2021Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd f..
CI
2021An unknown buyer agreed to acquire 10% stake in Guangdong Jiaying Pharmaceutical Co., L..
CI
More news
Financials
Sales 2021 575 M 85,2 M 85,2 M
Net income 2021 1,48 M 0,22 M 0,22 M
Net cash 2021 212 M 31,4 M 31,4 M
P/E ratio 2021 2 717x
Yield 2021 -
Capitalization 3 568 M 529 M 529 M
EV / Sales 2020 3,95x
EV / Sales 2021 6,59x
Nbr of Employees -
Free-Float 67,1%
Chart GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Duration : Period :
Guangdong Jiaying Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Xiao Yan Chen Chief Financial Officer